Freeze-All Strategy Increases Adenomyosis-Associated IVF Birth Rates Endocrinology Advisor
More here:
Freeze-All Strategy Increases Adenomyosis-Associated IVF Birth Rates - Endocrinology Advisor
Category Archives: Endocrinology
Cone physician in Rockingham Co. is top national lifestyle doc in fight against diabetes – Greensboro News & Record
REIDSVILLE Local endocrinologist Gebreselassie (Gebre) Nida has recently been recognized as a national leader in treatment of diabetes and promotion of healthy lifestyles.
The prestigious medical report card, the Marquis Whos Who, included Nida in its recent directory of top physicians, according to Cone Health officials.
Nida practices at Cone Healths Reidsville Endocrinology Associates.
While Nida is an accomplished endocrinology and diabetes physician, he is becoming known as an expert in the growing field of lifestyle medicine, according to Cone spokesman Doug Allred.
A marathon runner who practices a health lifestyle himself, Nida is passionate about preventing and reversing Type 2 diabetes and many lifestyle-related chronic diseases, Allred said in a news release.
Lifestyle medicine uses proven methods to make changes in diet, exercise and stress management to improve health. Much of the system centers on removing the root causes of chronic diseases, such as ultra-processed foods and drinks, from the diet.
Nidas vision is to expand this effective and better way of healing, Allred said in the release.
He credits his leaders and team members for the success of the Lifestyle Medicine Steering Committee at Cone Health.
Nida serves as a board member for Annie Penn Hospital Foundation and is the lead physician for the Rockingham County Diabetes Task Force. He leads and contributes to the Greensboro Chapter of Walk with a Doc.
A native of rural Ethiopia, Nida grew up tending animals in rugged conditions.
He raised cattle and sheep in an area without electricity and running water.
And because his father valued education, Nida was allowed to attend an elementary school he reached by walking one hour each way.
By age 12, Nida left home to pursue more specialized education and eventually made it to Addis Ababa University where he earned medical degree in 1999.
Soon after, Nida and his wife, Ethiopia Desta, immigrated to the United States where he pursued postgraduate studies, a residency in internal medicine and a fellowship in endocrinology, diabetes, and metabolism at Wayne State University in Michigan.
Nida joined Cone Health in 2012 where he recently added the new specialty Lifestyle Medicine with a new board certification from American College of Lifestyle Medicine.
An outdoors enthusiast, Nida has competed in 32 marathons, including five Boston Marathon races, and three major world marathons with a personal best time of 2:47:09 at age 48.
Follow this link:
Integrating Precision Medicine for Obesity into Type 2 Diabetes Management: A Comprehensive Overview from Past to … – Physician’s Weekly
The following is a summary of Precision medicine of obesity as an integral part of type 2 diabetes management past, present, and future, published in the December 2023 issue of Diabetes & Endocrinology by Szczerbinski, et al.
Several metabolic problems may be ascribed to obesity, which is a condition that is both difficult and varied. One of these metabolic problems is type 2 diabetes. Many people do not achieve lasting weight loss or improvements in metabolic health as a consequence of the fact that the treatment options that are now accessible for obesity are insufficient for some individuals.
It contributed to the fact that many people do not achieve persistent weight loss. The emphasis of this review is on metabolic consequences and the potential implications of these repercussions for personalized therapy of the illness. The study highlighted the developments that have taken place in the field of obesity genetics throughout the last ten years, with a specific focus on major discoveries that have taken place during the preceding five years.
There was also a discussion in this article on the potential role that genetics might have in determining the effectiveness of weight loss programs. Lastly, they provide a vision for the future of precision obesity therapy, which entails the development of an algorithm for the management of several illnesses that are based on obesity and tackles both obesity and the symptoms that accompany it. The algorithm will be used to treat obesity both directly and indirectly. On the other hand, the full realization of its potential and the improvement of metabolic health outcomes would need more research and concerted efforts.
Source: sciencedirect.com/science/article/abs/pii/S2213858723002322
Excerpt from:
Deciphering Diabetes Heterogeneity: Advancing Toward Precision Medicine in Diabetes Care – Physician’s Weekly
The following is a summary of Understanding diabetes heterogeneity: key steps towards precision medicine in diabetes, published in the December 2023 issue of Diabetes & Endocrinology by Leslie, et al.
Diabetes is a disorder that shows a great deal of heterogeneity. Yet, it can be diagnosed by detecting a single blood-borne metabolite, glucose, regardless of the underlying cause of the ailment. Disease categorization may become complicated, which might impede progress in research and medical treatment even though it is beneficial from a practical standpoint. For a study, researchers sought to discuss the heterogeneity of diabetes and highlight emerging techniques that might make treatment easier.
The approaches included combining three disease models that apply to all types of diabetes. These models are the gradient model, the threshold model, and the palette model, each individually. Multiple mechanisms that are meant to avoid or bypass metabolic dysfunction are responsible for preventing the further worsening of existing diabetes and the eventual appearance of problems associated with diabetes. Once diabetes has been established, these risks are maintained under control.
The effect of any disease risk factor will differ from person to person based on their history, diabetes-related tendencies, and environmental exposures. This means that the impact of any given disease risk factor will vary. Using precision medicine to define the resultant variability within diabetes, both in terms of the risk of complications and the risk of diabetes itself, can enhance health outcomes in the present and provide light on potential paths for innovative treatment in the future.
Source: sciencedirect.com/science/article/abs/pii/S2213858723001596
View post:
Sotagliflozin Treatment Safe Across Renal Spectrum – Endocrinology Advisor
Sotagliflozin Treatment Safe Across Renal Spectrum Endocrinology Advisor
See the article here:
Sotagliflozin Treatment Safe Across Renal Spectrum - Endocrinology Advisor